Breast cancer, Ovarian cancer
Results
Phase 2
This trial looked at mercaptopurine and methotrexate for people with breast or ovarian cancer who had an inherited fault in the BRCA1 or BRCA2 gene.
The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2014. The team published the results in 2020.
Recruitment start: 15 June 2011
Recruitment end: 20 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Shibani Nicum
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Oxford
This is Cancer Research UK trial number CRUK/10/049.
Last reviewed: 3 March 2023
CRUK internal database number: 6914
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
